Results 1 to 10 of about 39,541 (234)

Nonhormonal Treatment of Menopausal Vasomotor Symptoms. [PDF]

open access: yesJAMA Intern Med
This work discusses nonhormonal treatment of menopausal vasomotor symptoms.
Huang AJ, Faubion S, Grady D.
europepmc   +3 more sources

Association of Migraine and Vasomotor Symptoms. [PDF]

open access: yesMayo Clin Proc, 2023
To further examine a potential link between migraine and vasomotor symptoms as well as hypertension as a cardiovascular disease risk factor, potentially explaining the association in midlife women.We conducted a cross-sectional analysis from the Data Registry on Experiences of Aging, Menopause, and Sexuality using questionnaire data from women aged 45 ...
Faubion SS   +7 more
europepmc   +3 more sources

Menopause part I: Vasomotor symptoms (I)

open access: yesTaiwanese Journal of Obstetrics & Gynecology
Menopause, an aged process due to loss of permanent ovarian function (mainly decreased production of estrogen) without another pathological or physiological cause becomes one of the most health issues in the world.
Peng-Hui Wang   +3 more
doaj   +3 more sources

Fezolinetant’s efficacy and safety in treatment of vasomotor symptoms in postmenopausal women: a meta-analysis and GRADE evaluation of randomized controlled trials [PDF]

open access: yesEuropean Journal of Medical Research
Background Postmenopausal women are more likely to experience vasomotor symptoms (VMS), such as heat sensation and sweating. Recent trials have investigated fezolinetant in the treatment of VMS in postmenopausal women.
Abdallah R. Allam   +2 more
doaj   +2 more sources

Effects of insomnia and non-vasomotor menopausal symptoms on coronary heart disease risk: a mendelian randomization study

open access: yesHeliyon, 2023
Background: Previous studies suggested that vasomotor symptoms were associated with an increasing risk of coronary heart diseases (CHD) but not clear with menopausal symptoms other than vasomotor symptoms.
Ie-Bin Lian   +4 more
doaj   +1 more source

Vasomotor Symptoms: More Than Temporary Menopausal Symptoms [PDF]

open access: yesJournal of Menopausal Medicine, 2020
Vasomotor symptoms (VMS), such as hot flashes and night sweating, are classic menopausal symptoms experienced by a majority of perimenopausal and postmenopausal women. VMS have received a great deal of attention due to their relationship with cardiometabolic risk.
Ki-Jin Ryu   +11 more
openaire   +2 more sources

Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause

open access: yesBrazilian Journal of Psychiatry, 2020
Objective: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and
Marianna de B. Jaeger   +5 more
doaj   +1 more source

Vasomotor symptoms and metabolic syndrome [PDF]

open access: yesMaturitas, 2017
A vast majority of menopausal women suffer from vasomotor symptoms, such as hot flushes and night sweats, the mean duration of which may be up to 7-10 years. In addition to a decreased quality of life, vasomotor symptoms may have an impact on overall health.
Pauliina, Tuomikoski   +1 more
openaire   +2 more sources

Life‐Course Reproductive History and Cardiovascular Risk Profile in Late Mid‐Life: The CARDIA Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Reproductive events, that is, a preterm birth (PTB), small‐for‐gestational‐age infant (SGA), and vasomotor symptoms of menopause, are associated with subclinical atherosclerotic cardiovascular disease (ASCVD). We evaluated whether women with a
Abbi D. Lane‐Cordova   +7 more
doaj   +1 more source

Analysis of Mexican young women with primary ovarian insufficiency induced by gynaecological and haematological cancer management

open access: yesJournal of Obstetrics and Gynaecology, 2023
This was a retrospective study that included 114 women younger than 40 years with induced primary ovarian insufficiency. Patients who presented vasomotor symptoms had a higher proportion (26 [63.41%] versus 58 [79.45%], OR 2.23, 95% CI 0.95–5.23, p ...
Marisol García-García   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy